The Emergence of Carbapenem-Resistant Gram-Negative Bacteria in Mizoram, Northeast India

被引:4
|
作者
Ralte, Vanlalruati S. C. [1 ]
Loganathan, Archana [2 ]
Manohar, Prasanth [3 ]
Sailo, Christine Vanlalbiakdiki [4 ]
Sanga, Zothan [5 ]
Ralte, Lalremruata [6 ]
Zothanzama, John [4 ]
Leptihn, Sebastian [3 ,7 ]
Nachimuthu, Ramesh [2 ]
Kumar, Nachimuthu Senthil [4 ]
机构
[1] Civil Hosp Lunglei, Lunglei 796701, India
[2] Vellore Inst Technol, Sch Biosci & Technol, Antibiot Resistance & Phage Therapy Lab, Vellore 632014, Tamil Nadu, India
[3] Zhejiang Univ, Zhejiang Univ Univ Edinburgh Inst, Sch Med, Haining 314400, Peoples R China
[4] Mizoram Univ, Dept Biotechnol, Aizawl 796004, India
[5] Directorate Hlth Serv, Dept Hlth & Family Welf, Aizawl 796009, India
[6] Synod Hosp, Dept Microbiol, Durtlang 796025, India
[7] Univ Edinburgh, Coll Med & Vet Med, Edinburgh Med Sch, Infect Med,Biomed Sci, 1 George Sq, Edinburgh EH8 9JZ, Midlothian, Scotland
关键词
carbapenem-resistance; Gram-negative bacteria; Enterobacteriaceae; meropenem; antibiotic resistance; MODIFIED HODGE TEST; TAMIL-NADU;
D O I
10.3390/microbiolres13030027
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
(Background) Numerous reports on carbapenem resistance in different parts of India have been published, yet there are insufficient studies on the prevalence of antibiotic resistance in the northeast region of the country. This study evaluated the emergence of carbapenem resistance in the clinical isolates collected in Mizoram. (Results) A total of 141 Gram-negative clinical isolates were collected from the two hospitals, including the Civil Hospital in Lunglei and the Synod Hospital in Aizawl. The isolates include Escherichia coli (n = 62, 43.9%), Klebsiella spp. (n = 43, 30.4%), Pseudomonas aeruginosa (n = 9, 6.3%), Serratia marcescens (n = 3, 2.1%), Proteus mirabilis (n = 2, 1.4%), Shigella spp. (n = 4, 2.8%), Enterobacter spp. (n = 6, 4.2%) and Acinetobacter spp. (n = 12, 8.5%). The isolates were found to be resistant to meropenem (11%), colistin (48%), tigecycline (25%) and cefotaxime (50%). A total of four E. coli and one Shigella sonnei encoded the bla(OXA-48-like) gene. The bla(CTX-M-1) gene was detected in 13 isolates, of which eight were E. coli, two Shigella flexneri, and one isolates each of K. pneumoniae, K. oxytoca and Shigella sonnei, respectively. (Conclusion) Carbapenem-resistant Enterobacteriaceae are common among other parts of India, despite limited access to antibiotics, the emergence of resistance in the northeastern region is worrying.
引用
收藏
页码:342 / 349
页数:8
相关论文
共 50 条
  • [41] Molecular epidemiology of carbapenem-resistant gram-negative bacilli in Ecuador
    Claudia Soria-Segarra
    Carmen Soria-Segarra
    Marcos Molina-Matute
    Ivanna Agreda-Orellana
    Tamara Núñez-Quezada
    Kerly Cevallos-Apolo
    Marcela Miranda-Ayala
    Grace Salazar-Tamayo
    Margarita Galarza-Herrera
    Victor Vega-Hall
    José E. Villacis
    José Gutiérrez-Fernández
    BMC Infectious Diseases, 24
  • [42] Widespread cefiderocol heteroresistance in carbapenem-resistant Gram-negative pathogens
    Choby, Jacob E.
    Ozturk, Tugba
    Satola, Sarah W.
    Jacob, Jesse T.
    Weiss, David S.
    LANCET INFECTIOUS DISEASES, 2021, 21 (05): : 597 - 598
  • [43] Therapy of Infections due to Carbapenem-Resistant Gram-Negative Pathogens
    Lee, Chang-Seop
    Doi, Yohei
    INFECTION AND CHEMOTHERAPY, 2014, 46 (03): : 149 - 164
  • [44] Quercetin inhibits carbapenemase and efflux pump activities among carbapenem-resistant Gram-negative bacteria
    Pal, Arijit
    Tripathi, Anusri
    APMIS, 2020, 128 (03) : 251 - 259
  • [45] Polymyxin B adjuvants against polymyxin B- and carbapenem-resistant Gram-negative bacteria
    Salvaterra Pasquini, Joao Paulo
    Queiroz, Paula Assis
    Rodrigues do Amaral, Pedro Henrique
    da Silva, Thalita Camilo
    Souza Bonfim Mendonca, Patricia de
    Vandresen, Fabio
    Carvalho Ceolis, Joao Pedro
    de Lima Scodro, Regiane Bertin
    Caleffi-Ferracioli, Katiany Rizzieri
    Cardoso, Rosilene Fressatti
    Dias Siqueira, Vera Lucia
    FUTURE MICROBIOLOGY, 2024, 19 (17) : 1445 - 1454
  • [46] Epidemiology, Phenotypic and Genotypic Characterization of Carbapenem-Resistant Gram-Negative Bacteria from a Libyan Hospital
    Slimene, Khouloud
    El Salabi, Allaaeddin
    Dziri, Olfa
    Mathlouthi, Najla
    Diene, Seydina M.
    Mohamed, Elhussan Ahmed
    Amhalhal, Jadalla M. A.
    Aboalgasem, Mohammed O.
    Alrjael, Jomaa F.
    Rolain, Jean-Marc
    Chouchani, Chedly
    MICROBIAL DRUG RESISTANCE, 2023, 29 (08) : 333 - 343
  • [47] Clinical analysis of colistin sulfate in the treatment of pneumonia caused by carbapenem-resistant Gram-negative bacteria
    Xu, Hai-Chang
    Cui, Yan
    Wang, Xue-Ying
    Wu, Hai-Bo
    Li, Wei
    Wang, Dan
    Lin, Na
    Lin, Lin
    Zhang, Ying-Hui
    WORLD JOURNAL OF CLINICAL CASES, 2024, 12 (13)
  • [48] The Place of Meropenem–Vaborbactam in the Management of Carbapenem-Resistant Gram-Negative Infections
    Teena Chopra
    Infectious Diseases and Therapy, 2021, 10 : 633 - 635
  • [49] Early identification and optimal management of carbapenem-resistant Gram-negative infection
    Bedos, J. P.
    Daikos, G.
    Dodgson, A. R.
    Pan, A.
    Petrosillo, N.
    Seifert, H.
    Vila, J.
    Ferrer, R.
    Wilson, P.
    JOURNAL OF HOSPITAL INFECTION, 2021, 108 : 158 - 167
  • [50] Unresolved issues in the identification and treatment of carbapenem-resistant Gram-negative organisms
    Kois, Abigail K.
    Nicolau, David P.
    Kuti, Joseph L.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2020, 33 (06) : 482 - 494